Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
High Tide Inc. (HITI.V)
Calgary, AB, CA
High Tide Inc. operates as a prominent global player in the cannabis retail sector, with business activities spanning Canada, Europe, the United States, and other international markets. The company's portfolio is multifaceted, including the design, manufacturing, and distribution of various smoking accessories and cannabis-inspired lifestyle products. Beyond merchandise, High Tide is actively involved in the wholesale and direct retail of cannabis products, managing and franchising numerous licensed cannabis dispensaries. Furthermore, it offers data analytics services and runs the online retail platforms Grasscity.com and CBDcity.com. As of October 25, 2022, High Tide maintained a substantial retail presence with 149 locations throughout several Canadian provinces, including Ontario, Alberta, British Columbia, Manitoba, and Saskatchewan. Founded in 2009, this Calgary, Canada-based company was rebranded as High Tide Inc. in October 2018, having previously operated under the name High Tide Ventures Inc.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.53% | +2.15% | +0.61% | +7.44% | -13.54% | -9.54% | +8.50% | +104.94% | -63.72% | -44.67% | -44.67% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 5 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Pharmaceuticals: +7.8%+13.7% ★ Q2'26: +30.1% (vs Q2'25)
-
EPS growth Medical - Pharmaceuticals: +20.2%-1,056.7% Q2'26: +93.9% (vs Q2'25)
-
FCF margin FCF growth · Medical - Pharmaceuticals: +43.3%-6.4% Q2'26: +1.3% (vs Q2'25)
-
EBIT margin Medical - Pharmaceuticals: +6.8%-6.4% Q2'26: +4.5% (vs Q2'25)
-
ROIC Medical - Pharmaceuticals: +6.1%-18.6% Q2'26: +11.1% (vs Q2'25)
-
Share dilution Medical - Pharmaceuticals: +0.0%+1.5% Q2'26: +8.6% (vs Q2'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Pharmaceuticals: 0.21×-10.91× Q2'26: 1.92× (vs Q2'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Oct 2019 actual |
Oct 2020 actual |
Oct 2021 actual |
Oct 2022 actual |
Oct 2023 actual |
Oct 2024 actual |
Oct 2025 actual |
Oct 2026 6 Rev. Ana. 3 EPS Ana. |
Oct 2027 6 Rev. Ana. 3 EPS Ana. |
Oct 2028 2 Rev. Ana. 2 EPS Ana. |
Oct 2029 1 Rev. Ana. 1 EPS Ana. |
Oct 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
31.29M
est: 34.27M (-8.7%)
|
83.27M
est: 80.35M (+3.6%)
|
181.12M
est: 179.35M (+1.0%)
|
356.85M
est: 347.60M (+2.7%)
|
487.67M
est: 503.78M (-3.2%)
|
522.31M
est: 519.32M (+0.6%)
|
593.99M
est: 588.79M (+0.9%)
|
730.74M
724.31M – 741.65M
+24.1% YoY
|
820.63M
795.30M – 834.00M
+12.3% YoY
|
886.80M
868.66M – 900.68M
+8.1% YoY
|
918.70M
899.91M – 933.08M
+3.6% YoY
|
977.00M
957.02M – 992.29M
+6.3% YoY
|
| EBITDA |
-22.29M
est: 366.9K (-6,175.4%)
|
8.54M
est: 860.4K (+892.8%)
|
-1.96M
est: 1.92M (-202.1%)
|
-33.65M
est: 3.72M (-1,003.9%)
|
-4.20M
est: 21.45M (-119.6%)
|
33.78M
est: 22.12M (+52.8%)
|
-13.74M
est: 25.07M (-154.8%)
|
31.12M
30.85M – 31.58M
+24.1% YoY
|
34.95M
33.87M – 35.52M
+12.3% YoY
|
37.76M
36.99M – 38.36M
+8.1% YoY
|
39.12M
38.32M – 39.74M
+3.6% YoY
|
41.61M
40.75M – 42.26M
+6.3% YoY
|
| EBIT |
-23.69M
est: -2.46M (-864.3%)
|
1.88M
est: -5.76M (+132.5%)
|
-25.53M
est: -12.86M (-98.5%)
|
-63.82M
est: -24.93M (-156.0%)
|
-36.96M
est: 47.04M (-178.6%)
|
8.39M
est: 48.49M (-82.7%)
|
-38.05M
est: 54.98M (-169.2%)
|
68.23M
67.63M – 69.25M
+24.1% YoY
|
76.62M
74.26M – 77.87M
+12.3% YoY
|
82.80M
81.11M – 84.10M
+8.1% YoY
|
85.78M
84.03M – 87.12M
+3.6% YoY
|
91.22M
89.36M – 92.65M
+6.3% YoY
|
| Net Income |
-26.29M
est: -84.99M (+69.1%)
|
-6.35M
est: -24.28M (+73.8%)
|
-35.04M
est: -53.22M (+34.2%)
|
-70.85M
est: -30.43M (-132.8%)
|
-39.31M
est: -36.69M (-7.1%)
|
-4.34M
est: 163.8K (-2,747.0%)
|
-50.75M
est: -2.73M (-1,758.4%)
|
3.28M
3.20M – 3.35M
+220.0% YoY
|
15.97M
15.60M – 16.35M
+387.5% YoY
|
22.19M
21.37M – 23.01M
+38.9% YoY
|
38.62M
37.60M – 39.41M
+74.1% YoY
|
46.02M
44.80M – 46.96M
+19.1% YoY
|
| SGA |
29.47M
est: 8.42M (+249.9%)
|
22.64M
est: 19.75M (+14.7%)
|
54.27M
est: 44.07M (+23.1%)
|
90.90M
est: 85.42M (+6.4%)
|
101.21M
est: 115.70M (-12.5%)
|
101.79M
est: 119.27M (-14.7%)
|
113.78M
est: 135.22M (-15.9%)
|
167.83M
166.35M – 170.33M
+24.1% YoY
|
188.47M
182.65M – 191.54M
+12.3% YoY
|
203.67M
199.50M – 206.86M
+8.1% YoY
|
210.99M
206.68M – 214.30M
+3.6% YoY
|
224.38M
219.79M – 227.90M
+6.3% YoY
|
| EPS |
-1.99
est: -1.05 (-89.5%)
|
-0.42
est: -0.30 (-40.0%)
|
-0.83
est: -0.66 (-26.2%)
|
-1.13
est: -0.38 (-200.5%)
|
-0.53
est: -0.45 (-18.6%)
|
-0.05
est: 0.00 (-2,790.0%)
|
-0.62
est: -0.03 (-1,760.0%)
|
0.04
0.04 – 0.04
+220.0% YoY
|
0.20
0.19 – 0.20
+387.5% YoY
|
0.27
0.26 – 0.28
+38.5% YoY
|
0.47
0.46 – 0.48
+74.1% YoY
|
0.56
0.55 – 0.57
+19.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-06-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-06-12 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-06-11 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-06-10 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-06-09 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-06-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-06-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-06-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-06-03 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-06-02 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-06-01 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-26 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-25 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-19 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-14 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-13 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-12 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-11 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-01 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Harkirat Grover | Founder, Chief Executive Officer, President & Executive Chairman | 990.6K | male |
| Mayank Mahajan | Chief Financial Officer | 395.8K | male |
| Aman Sood | Chief Operating Officer | 376.6K | male |
| Omar Khan | Chief Communications & Public Affairs Officer | 282.2K | male |
| Andreas-Alexander Palalas | Chief Marketing Officer | 275.3K | male |
| Joy Lisa Avzar | Senior Vice President of Legal & Compliance | 253.0K | female |
| Shimshon Posen | Secretary & Treasurer | — | male |
| Carter Brownlee | Communications & Public Affairs Advisor | — | male |
| Krystal Dafoe | Director of Corporate Governance | — | — |
| Sandy Sharma | Vice President of Human Resources | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HITI.V
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
